Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 13.90% is 37% above its 5-year average of 10.17%, near the high end of its 5-year range (4.41%–13.90%).
As of the fiscal period ended Wednesday, December 31, 2025. 1.13% above its 12-month average of 13.75%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
13.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
13.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
11.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
10.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
10.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
12.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
12.64%
CURRENT VS TTM AVG
+1.13%
CURRENT VS 3Y AVG
+16.59%
CURRENT VS 5Y AVG
+36.65%
CURRENT VS 10Y AVG
+30.14%
CURRENT VS 15Y AVG
+15.77%
CURRENT VS 20Y AVG
+9.97%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+62.95%
vs the sector median at left
Bristol-Myers Squibb Company
Market Cap
$133.37B
Return on Invested Capital (ROIC)
13.90%
TTM Avg
13.75%
3Y Avg
11.92%
5Y Avg
10.17%
Market Cap
$133.25B
Return on Invested Capital (ROIC)
4.72%
TTM Avg
4.17%
3Y Avg
4.46%
5Y Avg
4.93%
Market Cap
$131.47B
Return on Invested Capital (ROIC)
13.03%
TTM Avg
11.66%
3Y Avg
9.40%
5Y Avg
7.60%
Market Cap
$137.13B
Return on Invested Capital (ROIC)
5.72%
TTM Avg
5.90%
3Y Avg
6.54%
5Y Avg
6.70%
Market Cap
$124.86B
Return on Invested Capital (ROIC)
8.53%
TTM Avg
10.14%
3Y Avg
10.34%
5Y Avg
10.08%
Market Cap
$124.82B
Return on Invested Capital (ROIC)
13.71%
TTM Avg
12.85%
3Y Avg
12.25%
5Y Avg
11.92%
Market Cap
$142.54B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
9.06%
3Y Avg
10.60%
5Y Avg
10.43%
Market Cap
$121.09B
Return on Invested Capital (ROIC)
18.12%
TTM Avg
10.38%
3Y Avg
14.75%
5Y Avg
17.51%
Market Cap
$109.30B
Return on Invested Capital (ROIC)
6.13%
TTM Avg
6.11%
3Y Avg
5.46%
5Y Avg
5.53%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Company (BMY) | $133.37B | 13.90% | 13.75% | 11.92% | 10.17% |
| CVS Health Corp. (CVS)vs › | $133.25B | 4.72% | 4.17% | 4.46% | 4.93% |
| AstraZeneca PLC (AZN)vs › | $131.47B | 13.03% | 11.66% | 9.40% | 7.60% |
| Danaher Corporation (DHR)vs › | $137.13B | 5.72% | 5.90% | 6.54% | 6.70% |
| Stryker Corporation (SYK)vs › | $124.86B | 8.53% | 10.14% | 10.34% | 10.08% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.82B | 13.71% | 12.85% | 12.25% | 11.92% |
| Pfizer Inc. (PFE)vs › | $142.54B | 8.84% | 9.06% | 10.60% | 10.43% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.09B | 18.12% | 10.38% | 14.75% | 17.51% |
| Medtronic plc (MDT)vs › | $109.30B | 6.13% | 6.11% | 5.46% | 5.53% |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 21.53% | 11.95% | 11.58% | 9.92% |
ROIC
13.9%
ROE
41.6%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 13.90% |
| 2024-12-31 | 13.59% |
| 2023-12-31 | 10.59% |
| 2022-12-31 | 9.61% |
| 2021-12-31 | 8.93% |
| 2020-12-31 | 4.41% |
| 2019-12-31 | 3.89% |
| 2018-12-31 | 20.36% |
| 2017-12-31 | 3.99% |
| 2016-12-31 | 15.26% |
| 2015-12-31 | 12.96% |
| 2014-12-31 | 10.32% |
| 2013-12-31 | 10.54% |
| 2012-12-31 | 15.00% |
| 2011-12-31 | 20.10% |
| 2010-12-31 | 18.65% |
| 2009-12-31 | 15.98% |
| 2008-12-31 | 16.41% |
| 2007-12-31 | 14.99% |
| 2006-12-31 | 10.64% |
| 2005-12-31 | 15.32% |
| 2004-12-31 | 13.72% |
| 2003-12-31 | 18.09% |
| 2002-12-31 | 19.65% |
| 2001-12-31 | 29.56% |
| 2000-12-31 | 36.97% |
| 1999-12-31 | 32.05% |
| 1998-12-31 | 30.72% |
| 1997-12-31 | 30.26% |
| 1996-12-31 | 27.66% |
